Rojelio Mejia1, Thomas B Nutman. 1. Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892-0425, USA.
Abstract
PURPOSE OF REVIEW: This review discusses the latest approaches to the diagnosis and treatment of patients with strongyloidiasis, with an emphasis on infection in the immunocompromised host and the risk for disseminated strongyloidiasis. RECENT FINDINGS: The differences in acute, chronic, accelerated autoinfection, and disseminated disease in Strongyloides stercoralis infection are explored with particular emphasis on early diagnosis, treatment, and prevention. The goals of treatment are investigated for the different infection states. Predisposing risks for dissemination are delineated, and the roles played for newer diagnostics in the identification of at-risk individuals are detailed. SUMMARY: The use of newer diagnostic tests and broader screening of immunocompromised patients from Strongyloides-endemic areas is of paramount importance, particularly if prevention of life-threatening dissemination is the goal.
PURPOSE OF REVIEW: This review discusses the latest approaches to the diagnosis and treatment of patients with strongyloidiasis, with an emphasis on infection in the immunocompromised host and the risk for disseminated strongyloidiasis. RECENT FINDINGS: The differences in acute, chronic, accelerated autoinfection, and disseminated disease in Strongyloides stercoralis infection are explored with particular emphasis on early diagnosis, treatment, and prevention. The goals of treatment are investigated for the different infection states. Predisposing risks for dissemination are delineated, and the roles played for newer diagnostics in the identification of at-risk individuals are detailed. SUMMARY: The use of newer diagnostic tests and broader screening of immunocompromised patients from Strongyloides-endemic areas is of paramount importance, particularly if prevention of life-threatening dissemination is the goal.
Authors: M Mascarello; F Gobbi; A Angheben; M Gobbo; G Gaiera; M Pegoraro; M Lanzafame; D Buonfrate; E Concia; Z Bisoffi Journal: Ann Trop Med Parasitol Date: 2011-12
Authors: Paola Vargas; Alejandro J Krolewiecki; Adriana Echazú; Marisa Juarez; Pamela Cajal; Jose F Gil; Nicolás Caro; Julio Nasser; Patrick Lammie; Rubén O Cimino Journal: Am J Trop Med Hyg Date: 2017-07 Impact factor: 2.345
Authors: Evan E Yung; Cassie M K L Lee; Joshua Boys; Daniel J Grabo; James L Buxbaum; Parakrama T Chandrasoma Journal: Am J Trop Med Hyg Date: 2014-08-04 Impact factor: 2.345